NCT04161248 2026-02-02
Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
Canadian Cancer Trials Group
Phase EARLY_PHASE1 Recruiting
Clinical Trials
4 trialsNCT06520449 2025-09-25
NTA-476
Melbourne Theranostic Innovation Centre
Phase EARLY_PHASE1 Completed
NCT04139304 2025-06-29
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
AIDS Malignancy Consortium
Phase EARLY_PHASE1 Recruiting
NCT00606970 2013-05-07
Safety Assessment of Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy
New Hope Medical Center
Phase EARLY_PHASE1 Withdrawn